Reveal Officially Releases its Logikcull Platform Throughout Europe
Reveal, the global provider of the leading AI-powered eDiscovery and investigations suite of technologies,announced today the launch of its Logikcull platform in Europe. This strategic expansion introduces customers to Logikcull’s lightweight, self-service option, while simultaneously broadening access to its enterprise-grade, feature-rich platform, driven by the most powerful AI engine in the industry. Reveal’s dual-platform approach uniquely positions the company to offer customers across Europe and beyond more choice in how to solve their diverse set of legal challenges.
“The introduction of Logikcull by Reveal to the European market highlights our continued commitment to bridging the justice gap by automating the practice of law for all - not just a privileged few. In less than a year since our acquisition of Logikcull, I’m proud that our strategic investment in Logikcull has taken the platform from a national success story to now a global one,” said Wendell Jisa, Founder & CEO of Reveal. “Our Logikcull platform offers unparalleled accessibility to a variety of eDiscovery tools, while our Reveal enterprise-grade platform, driven by powerful AI, tackles even the most complex legal matters. Together, we’re offering legal teams the most adaptable and scalable technology solutions for managing their evolving eDiscovery needs.”
The availability of Logikcull in EMEA introduces a simple and cost-effective way for legal teams to enhance efficiency and control over eDiscovery workflows. It also better positions EMEA organisations to manage and solve legal challenges such as Data Subject Access Requests (DSARs) and Freedom of Information (FOI) requests, while ensuring compliance with regional GDPR and data privacy regulations. Designed to support corporate legal departments, government and municipal legal teams, law firms, and solo practitioners, Logikcull’s self-service capabilities streamline access to automated tools and offer the following day-one benefits:
- Multi-Purpose, Dual Platform Approach: Reveal has developed a scalable and adaptable ecosystem for the legal industry through its two industry-leading platforms. Logikcull offers self-service eDiscovery capabilities, while Reveal provides a full range of solutions, including information governance, early case assessment, legal hold, data collection, processing, document review, and trial presentation. Both platforms are underpinned by one of the most powerful AI engines in legal technology, ensuring robust and efficient performance across all functions.
- Empowering Legal Professionals with Choice: Reveal understands that legal challenges are never one size fits all, which is why the company has brought together the best of self-service and an AI-powered full-service platform to appropriately address the scale and complexity of any legal case with optimal efficiency.
- Bridging the Justice Gap: Reveal is the only legal technology company to democratise eDiscovery for all legal matters, offering any business – whether small or large – access to its self-service and leading AI-powered solutions.
- Customised eDiscovery Experience: Reveal's expanded team of eDiscovery experts ensures that clients receive tailored solutions and guidance to navigate complex litigation challenges. Reveal will continue to foster a culture of innovation and collaboration with its European customers, pushing the boundaries of legal automation.
Reveal continues to automate the practice of law, transforming how legal professionals, from solo practitioners to Am Law 100 firms, Fortune 500 companies, and government agencies, leverage the most advanced AI technology available to drive the eDiscovery process. For more information about Reveal's AI-powered eDiscovery platform, please visit www.revealdata.com.
About Reveal
Reveal is a leading AI-powered platform for eDiscovery, document review, legal hold and investigations. The company has a deep history in driving the adoption of legal automation, which is underpinned by its leading processing technology, visual analytics, and artificial intelligence capabilities. Reveal's software combines technology and human guidance to transform structured and unstructured data into actionable insight. We help organizations, including law firms, corporations, government agencies, and intelligence services, uncover more useful information faster by providing a world-class user experience and AI technology that is embedded within every phase of the eDiscovery process.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240917550261/en/
Contacts
Media Contact:
Liz Whelan
312.315.0160
lwhelan@revealdata.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Koch Ag & Energy Solutions Selects Cognite to Create Transformative Change in Operations Through Data Discovery & Contextualization17.9.2024 15:00:00 CEST | Press release
Cognite, the Data and AI authority for industry, and Koch Ag & Energy Solutions (KAES), a global provider of solutions for the agriculture, energy, and chemical markets, today announced a collaboration focusing on leveraging Cognite Data Fusion® to accelerate their digital transformation journey. This collaboration will result in agile data-driven execution in maintenance strategy, turnaround execution, and general efficiency gains across all plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240823846729/en/ Together, KAES and Cognite will deploy Cognite Data Fusion and co-innovate on custom, Generative AI solutions to accelerate KAES’s data journey, creating new ways of work in operations. Cognite Data Fusion will provide one foundation for operational data, which will be contextualized and represented in models for various tailored end-user applications for optimizing maintenance and operations. AI will be leveraged t
Percona Redefines Cloud-Native Database Management with Percona Everest: the World's First Open Source Public DBaaS Alternative17.9.2024 15:00:00 CEST | Press release
Percona, a global leader in enterprise-grade open source database software and services, today announced that its groundbreaking new database platform, Percona Everest, is now generally available to the public. Percona Everest is an open source, cloud-native database platform designed to deliver similar core capabilities and conveniences provided by database-as-a-service (DBaaS) offerings but without the burden of vendor lock-in and associated challenges. Percona Everest facilitates the work of developers, QA engineers, DevOps engineers, database administrators, and anyone who could benefit from self-serve deployment and management of MySQL, PostgreSQL and MongoDB on Kubernetes. Percona Everest simplifies database management and enables database deployment standardization across multiple clouds and environments. Percona Everest helps enterprises accelerate business operations through its reliable, scalable, and secure cloud-native database infrastructure architecture. “Percona Everest
Orbis Medicines and Vivtex Form Research & Exclusive Licensing Collaboration to Support Orbis Development of Next-Generation Orally Dosable ‘ n Cycles’17.9.2024 14:00:00 CEST | Press release
Orbis Medicines, a leader in oral macrocycle drug discovery, today announced a research collaboration and option to an exclusive license with Vivtex, a biotech company aiming to transform the development of oral biologic therapies for major diseases. The collaboration will enable Orbis to utilize Vivtex’s GI-ORIS™ platform for gut permeability screening to evaluate the oral bioavailability of Orbis’ portfolio of next-generation macrocycle drugs it calls ‘nCycles’. “This collaboration extends our ability to design for oral bioavailability into later stages of preclinical development with Vivtex’s extensively validated ex vivo porcine gut model, which is highly informative for human gut interactions. Our goal is faster development of the highest quality candidates possible for clinical entry as we work towards bringing a new generation of macrocycle drugs to patients,” said Simon Feldbæk, Managing Director and Chief Development Officer at Orbis. Under the agreement, the companies will co
Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix ® Assessment17.9.2024 14:00:00 CEST | Press release
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix® Assessment for Electronic Data Capture (EDC) in life sciences. The report, which evaluated 20 providers, highlighted Medidata Rave EDC for its seamless integration with wearables, sensors, and EHRs, along with its advanced capabilities in source data verification, AI-driven query management, and adverse event handling. Rave EDC earned recognition for its intuitive, low-code design, enabling rapid implementation of protocol amendments, and simplifying the creation of electronic case report forms (eCRFs), while maintaining data quality and integrity for clinical trial sponsors. “We are honored to be recognized as a Leader in EDC by Everest Group,” said Anthony Costello, CEO, Medidata. “Rave EDC, the industry gold standard, has led electronic data capture for decades. Given the constantly evolving
Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing17.9.2024 14:00:00 CEST | Press release
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Kaitie Kramer has joined the company as vice president of marketing. She will lead the marketing strategy for the company and its growing portfolio of single cell solutions including Evercode™ Whole Transcriptome, Evercode™ TCR, Evercode™ BCR, and CRISPR Detect platforms. “As Parse gains market share in the U.S. and abroad, we’re continuing to hire talented people who can lead us through the next phase of our growth,” noted Parse CEO and co-founder Alex Rosenberg, PhD. “Kaitie’s deep level of experience in this market will be a huge asset for Parse and we’re fortunate to have her as part of our leadership team moving forward.” Kramer brings more than 20 years of commercial biotech experience to the role and joins Parse from Twist Bioscience, where she served as senior director of commercial marketing, overseeing key initiatives to help drive growth and brand awareness
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom